CD274 and neoplasm: As IL-12 and PD-L1 blockade are also associated with improved NK cell anti-tumor activity37,38, we next examined whether CAdTrio-derived IL-12 and PD-L1 blocker additively increased NK cell anti-PDAC activity (Fig. 6b).